Publications 2023

Ihler HM, Lyngstad SH, Gardsjord ES, Widing LH, Flaaten CB, Åsbø G, Wold KF, Engen MJ, Simonsen C, Ueland T, Lagerberg TV, Melle I, Romm KL (2023)
The trajectory of two negative symptom dimensions in first-episode psychosis and the role of cannabis use: A 10-year follow-up study
Schizophr Res, 252, 317-325
DOI 10.1016/j.schres.2023.01.024, PubMed 36706477

Lyngstad SH, Lyne JP, Ihler HM, van der Meer L, Færden A, Melle I (2023)
Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders
Schizophr Bull (in press)
DOI 10.1093/schbul/sbad070, PubMed 37193675

Publications 2022

Ihler HM (2022)
Cannabis - miracle medicine or psychosis-inducing drug?
Tidsskr Nor Laegeforen, 142 (10)
DOI 10.4045/tidsskr.21.0891, PubMed 35763855

Publications 2021

Ihler HM, Lagerberg TV, Lyngstad SH, Melle I, Romm KL (2021)
Exploring the relationship between recency and frequency of cannabis use and diminished expression and apathy as two dimensions of negative symptoms in first episode psychosis. A one-year follow-up study
Schizophr Res, 236, 89-96
DOI 10.1016/j.schres.2021.08.004, PubMed 34454305

Publications 2020

Ihler HM, Meyrel M, Hennion V, Maruani J, Gross G, Geoffroy PA, Lagerberg TV, Melle I, Bellivier F, Scott J, Etain B (2020)
Misperception of sleep in bipolar disorder: an exploratory study using questionnaire versus actigraphy
Int J Bipolar Disord, 8 (1), 34
DOI 10.1186/s40345-020-00198-x, PubMed 33215273

Lyngstad SH, Gardsjord ES, Engen MJ, Haatveit B, Ihler HM, Wedervang-Resell K, Simonsen C, Melle I, Færden A (2020)
Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
Eur Arch Psychiatry Clin Neurosci, 270 (6), 709-722
DOI 10.1007/s00406-020-01112-3, PubMed 32130475